Pernix Therapeutics (PTX) Sets New 52-Week Low at $0.75

Share on StockTwits

Pernix Therapeutics Holdings Inc (NASDAQ:PTX) shares reached a new 52-week low during trading on Monday . The stock traded as low as $0.75 and last traded at $0.76, with a volume of 171568 shares trading hands. The stock had previously closed at $0.85.

Separately, ValuEngine raised shares of Pernix Therapeutics from a “hold” rating to a “buy” rating in a research note on Monday, August 20th.

The company has a quick ratio of 0.71, a current ratio of 0.77 and a debt-to-equity ratio of -1.37.

Pernix Therapeutics (NASDAQ:PTX) last posted its quarterly earnings data on Thursday, August 9th. The specialty pharmaceutical company reported ($1.13) EPS for the quarter. The firm had revenue of $21.09 million for the quarter.

Pernix Therapeutics Company Profile (NASDAQ:PTX)

Pernix Therapeutics Holdings, Inc, a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription drugs primarily for the United States market. It targets underserved therapeutic areas, such as central nervous system (CNS), including pain, neurology, and psychiatry.

Recommended Story: How are the companies in the S&P 500 selected?

Receive News & Ratings for Pernix Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pernix Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply